160 related articles for article (PubMed ID: 31088489)
1. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient?
Antunes FD; Silva Junior CL; Cerqueira KS; do Livramento Faro M; Cipolotti R
Orphanet J Rare Dis; 2019 May; 14(1):108. PubMed ID: 31088489
[TBL] [Abstract][Full Text] [Related]
2. Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
Antunes FD; Propheta VGS; Vasconcelos HA; Cipolotti R
Ann Hematol; 2017 Jul; 96(7):1121-1125. PubMed ID: 28361297
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the DN4, S-LANSS, and painDETECT screening questionnaires to detect the neuropathic pain components in people with acute whiplash-associated disorders: a cross-sectional study.
Ríos-León M; Taylor J; Segura-Fragoso A; Barriga-Martín A
Pain Med; 2024 May; 25(5):344-351. PubMed ID: 38150190
[TBL] [Abstract][Full Text] [Related]
4. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
[TBL] [Abstract][Full Text] [Related]
5. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.
Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ
West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
[TBL] [Abstract][Full Text] [Related]
7. Neuropathic pain in patients with sickle cell disease.
Brandow AM; Farley RA; Panepinto JA
Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience.
Cregan M; Puri L; Kang G; Anghelescu D
Pediatr Blood Cancer; 2022 Apr; 69(4):e29583. PubMed ID: 35147289
[TBL] [Abstract][Full Text] [Related]
9. Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?
Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Pullum C; Schlaeger JM; Fillingim RB; Wilkie DJ
Pain Pract; 2016 Mar; 16(3):282-93. PubMed ID: 25581383
[TBL] [Abstract][Full Text] [Related]
10. Pain phenotype in patients with knee osteoarthritis: classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study.
Moreton BJ; Tew V; das Nair R; Wheeler M; Walsh DA; Lincoln NB
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):519-28. PubMed ID: 25155472
[TBL] [Abstract][Full Text] [Related]
11. Which scale is more useful to detect diabetic neuropathic pain?: A cross-sectional study.
Ünlütürk Z; Öztekin SNS; Alkan H; Şenol H; Betaş S; Erdoğan Ç
BMC Endocr Disord; 2022 Mar; 22(1):56. PubMed ID: 35255868
[TBL] [Abstract][Full Text] [Related]
12. Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.
Brandow AM; Farley RA; Panepinto JA
Pediatr Blood Cancer; 2015 Sep; 62(9):1501-11. PubMed ID: 25976161
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
[TBL] [Abstract][Full Text] [Related]
14. A QST-based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors.
Dyal BW; Ezenwa MO; Yoon SL; Fillingim RB; Yao Y; Schlaeger JM; Suarez ML; Wang ZJ; Molokie RE; Wilkie DJ
Pain Pract; 2020 Feb; 20(2):168-178. PubMed ID: 31553824
[TBL] [Abstract][Full Text] [Related]
15. Neuropathic pain in individuals with sickle cell disease.
Sharma D; Brandow AM
Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
[TBL] [Abstract][Full Text] [Related]
16. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review.
Mathieson S; Maher CG; Terwee CB; Folly de Campos T; Lin CW
J Clin Epidemiol; 2015 Aug; 68(8):957-66. PubMed ID: 25895961
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population.
Hamdan A; Luna JD; Del Pozo E; Gálvez R
Eur J Pain; 2014 Jan; 18(1):101-9. PubMed ID: 23776139
[TBL] [Abstract][Full Text] [Related]
18. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
[TBL] [Abstract][Full Text] [Related]
19. Determinants of non-nociceptive pain in Rheumatoid Arthritis.
Martins Rocha T; Pimenta S; Bernardo A; Bernardes M; Barbosa M; Lucas R; Vollert J; Costa L; Maier C
Acta Reumatol Port; 2018; 43(4):291-303. PubMed ID: 30641538
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic pain in sickle cell disease: measurement and management.
Glaros A; Brandow AM
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
